The CHEK2(*)1100delC mutation has no major contribution in oesophageal carcinogenesis

Por Koppert, L B, Schutte, M, Abbou, M, Tilanus, H W, Dinjens, W N M
Publicado em 2004

Prognosis of residual axillary disease after neoadjuvant chemotherapy in clinically node-positive breast cancer patients: isolated tumor cells and micrometastases carry a better pr...

Por van Nijnatten, T. J. A., Simons, J. M., Moossdorff, M., de Munck, L., Lobbes, M. B. I., van der Pol, C. C., Koppert, L. B., Luiten, E. J. T., Smidt, M. L.
Publicado no Breast Cancer Res Treat (2017)

Frequent loss of the AXIN1 locus but absence of AXIN1 gene mutations in adenocarcinomas of the gastro-oesophageal junction with nuclear β-catenin expression

Por Koppert, L B, van der Velden, A W, van de Wetering, M, Abbou, M, van den Ouweland, A M W, Tilanus, H W, Wijnhoven, B P L, Dinjens, W N M
Publicado em 2004

Timing of risk reducing mastectomy in breast cancer patients carrying a BRCA1/2 mutation: retrospective data from the Dutch HEBON study

Por Wevers, M. R., Schmidt, M. K., Engelhardt, E. G., Verhoef, S., Hooning, M. J., Kriege, M., Seynaeve, C., Collée, M., van Asperen, C. J., Tollenaar, R. A. E. M., Koppert, L. B., Witkamp, A. J., Rutgers, E. J. T., Aaronson, N. K., Rookus, M. A., Ausems, M. G. E. M.
Publicado no Fam Cancer (2015)